Synapsing: Research project on mental illness starts

Project start: Together with more than 10 partners from all over Europe, the Synapsing project begins at the NMI. The aim is to research synapse dysfunction in mental and neurodegenerative diseases, to develop blood biomarkers for diagnosis and therapy monitoring and to analyze socio-economic risk factors.
The NMI's tasks include the production of stem cell-derived nerve cells from patients (e.g. schizophrenia and frontotemporal dementia) and the identification of functional biomarkers, i.e. changes in neuronal network activity.
More information on the project in the press release of the Institut de Recerca de l'Hospital de la Santa Creu: : https://www.recercasantpau.cat/en/now/lir-sant-pau-liderara-synapsing-un-innovador-projecte-del-programa-horizon-europe-per-avancar-en-el-diagnostic-i-tractament-de-trastorns-psiquiatrics-i-malalties-neurodegeneratives/